PA
GRTS

Parallel Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Parallel Advisors’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-204
Closed -$3K – 3336
2021
Q4 		$3K Buy
+204
New +$2.26K ﹤0.01% 2634

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Parallel Advisors's GRTS Position: Q1 2022 in Review

Parallel Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2022, closing a stake of 204 shares — an estimated $3K sold.

Parallel Advisors first reported a position in GRTS in Q4 2021 and held it in 1 quarter. The position peaked at $3K in Q4 2021. 117 funds tracked by Wall St. Rank hold GRTS as of Q1 2022.

  • Parallel Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Parallel Advisors sold 204 Gritstone bio, Inc. Common Stock shares in Q1 2022, an estimated $3K.
  • Parallel Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Parallel Advisors's Gritstone bio, Inc. Common Stock position peaked at $3K in Q4 2021.
  • 117 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2022.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.